Theralase Technologies Inc. develops and commercializes medical laser technologies for healthcare applications, focusing on oncology and pain management. The company operates through two main divisions: the Anti-Cancer Therapy (ACT) division, which combines Photo Dynamic Compounds (PDCs) with laser technologies to target cancer, bacteria, and viruses; and the Cool Laser Therapy (CLT) division, which produces laser products approved for pain relief and tissue healing. Theralase serves healthcare practitioners and patients primarily in North America.
